Latest Breaking News On - Managing directorgv prasad - Page 1 : comparemela.com

Dr Reddy s Q4FY23 consolidated PAT jumps 996 pc YoY to Rs 959 cr | Indiablooms - First Portal on Digital News Management

Hyderabad: Hyderabad-based Pharma giant Dr Reddy’s Lab on Wednesday reported a consolidated net profit of Rs 959 crore for the fourth quarter ended March 2023, up 996 percent over Rs 87.5 crore reported in the corresponding quarter in the previous year.

United statesManaging directorgv prasadNorth americaLurasidone tabletsLubiprostone capsulesSunitinib capsulesNelarabine injectionPharmaceutical servicesActive ingredientsYderabad hyderabad based pharma giant dr reddy rsquos lab on wednesday reporteda consolidated net profit of rs 959 crore for the fourth quarter ended march 2023P 996 percent over rs 87 5 crore reported in the corresponding quarter previous year

Dr Reddy s Laboratories Q1 net profit jumps 108 per cent to Rs 1,188 crore

Dr Reddy s Laboratories Q1 net profit jumps 108 per cent to Rs 1,188 crore
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

Reddy laboratorieDr reddy laboratories coResearch developmentLaboratories co chairmanManaging directorgv prasad

Business News | Dr Reddy s Laboratories Q1 Net Profit Jumps 108 Per Cent to Rs 1,188 Crore

Get latest articles and stories on Business at LatestLY. Dr Reddy s Laboratories on Thursday reported a consolidated net profit of Rs 1,187.60 crore for the first quarter of the current financial year as compared to Rs 570.80 crore in the corresponding period of the last year, registering a year-on-year growth of 108 per cent. Business News | Dr Reddy s Laboratories Q1 Net Profit Jumps 108 Per Cent to Rs 1,188 Crore.

Reddy laboratorieDr reddy laboratories coResearch developmentLaboratories co chairmanManaging directorgv prasad

Latest News | Dr Reddy s Laboratories to Introduce Molnupiravir to Treat COVID-19 Shortly

Get latest articles and stories on Latest News at LatestLY. Dr Reddy s Laboratories on Tuesday said it will soon introduce antiviral drug Molnupiravir capsules (200mg) for the treatment of adult patients with COVID-19 across the country. Latest News | Dr Reddy s Laboratories to Introduce Molnupiravir to Treat COVID-19 Shortly.

Andhra pradeshNew delhiMerck sharpe dohmeDr reddy coExpert committeeSebi clears amendmentsVarious regulationsTightens normsBharat biotech targets one billion dosesDrugs controller generalManaging directorgv prasadSubject expert committee

Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use

With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio

Andhra pradeshHimachal pradeshSun pharmaK nithyananda reddyRehana khanB partha saradhi reddyRaman mehtaOptimus pharmaUmang vohraAurobindo pharmaKirti ganorkarCipla ltdHetero group of companiesTorrent pharmaceuticals ltdSun pharmaceutical industriesStrides pharma science ltd